A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
JOIN AIDSMEDS YouTube

Back to home » Treatment News » Top Stories

Most Popular Stories
An Almost Normal Life Expectancy for People With HIV?
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
A 15-Year Jump in Life Expectancy for People With HIV
Misleading News Reports Suggest HIV Cure Is Near
New HIV Drug Class Shows Promise
Gene Therapy Shows Promise in Controlling HIV
Potential Microbicide Tricks HIV Into Sudden Death
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to news@aidsmeds.com.

Click here for more news


emailprint

December 8, 2009

Researchers Engineer HIV-Killing Cells From Stem Cells

Researchers at the University of California in Los Angeles (UCLA) have demonstrated it is possible to engineer new HIV-specific killer CD8 cells from stem cells in the blood, according to an announcement by UCLA. The novel treatment approach, introduced in December in PLoS One, has a long way to go before it could be tested in humans, but it shows promise to fight other illnesses in addition to HIV/AIDS.

People who are naturally able to control HIV for long periods of time have high numbers of a type of an immune cell known as a cytotoxic T-lymphocyte (CTL) that is specific to HIV. Conversely, low levels of HIV-specific CTLs have been associated with more rapid disease progression. Researchers have attempted to increase a person’s HIV-specific CTL numbers by expanding the population of cells outside the body and then reinfusing them, but this process didn’t work because the cells did not live long and function fully.

To determine whether it might be possible to generate a large population of fully functional and long-lived HIV-specific CTLs, Scott Kitchen, PhD, and his colleagues at UCLA cloned a T-cell receptor from an HIV-specific CTL and then used it to engineer human stem cells that could fight HIV. The new HIV-specific CTLs were grown in human thymus tissue implanted in specially bred mice.

Kitchen’s team found that the cells lived long, reproduced and appeared to recognize HIV.

Challenges remain, however. First, according to Kitchen and his colleagues, expanded CTLs will have to be cloned and expanded for each individual, a time-consuming and costly process. One person’s CTLs cannot be used in another person. Second, because HIV can escape existing CTLs by mutating, it might be necessary to expand a variety of CTL populations in an individual in order to control HIV. Third, researchers must next demonstrate in more sophisticated models whether it is possible to engineer functional cells that can reproduce and thrive in humans.

Despite these challenges, the team is encouraged by this initial success. “This approach could be used to combat a variety of chronic viral diseases,” said study coauthor and fellow UCLA professor Jerome Zack, PhD. “It’s like a genetic vaccine.”

Search: Stem cells, cytotoxic T-lymphocytes, CTL, CD8, killer cells, Scott Kitchen, Jerome Zack


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team reviews all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (4 total)


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    aqua_31206
    Macon
    Georgia


    Newhopenate
    New Hope
    Pennsylvania


    ernienyc
    Bronx
    New York


    blaze11212
    brooklyn
    New York
Click here to join POZ Personals!
Conference Coverage

21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014


7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013


20th Conference on Retroviruses and Opportunistic Infections
(CROI 2013)
Atlanta, GA
March 3 - 7, 2013


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.